SISU Probi-digestis 30 billion
Natural health product licensed in Canada
- Other names
- Integris, Probi-digestis 30 billion
- Licence holder
- SISU
- NPN or DIN-HM
- 80045949
- Status
- Active licence
- Licence date
- 31 October 2013
- Revision date
- 18 February 2015
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Acide ascorbique, Lécithine, Sucrose, Fécule de pomme de terre, Hypromellose, Phosphate de dipotassium, Phosphate de potassium monobasique, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 day |
Uses authorised in Canada
Provides live microorganisms that temporarily modify gut flora. Probiotics that temporarily modify gut flora. Source of probiotics. Helps support gastrointestinal health. Helps to provide symptomatic relief of abdominal pain and discomfort associated with irritable bowel syndrome (IBS).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product. This product has come into contact with soy. If you have a soy allergy, do not use this product.
- Précautions et mises en garde
If you have nausea, fever, vomiting, bloody diarrhea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen or persist beyond 3 days, discontinue use & consult a health care practitioner.
Source
Official Health Canada record, licence 80045949
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed. Photograph the packaging